| Syed Mustafa Zaidi, | |
|
119 Oakfield Dr, Brandon, FL 33511-5779 | |
| (407) 788-1906 | |
| Not Available |
| Full Name | Syed Mustafa Zaidi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 119 Oakfield Dr, Brandon, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003213604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301105108 (Michigan) | Secondary |
| 207R00000X | Internal Medicine | ME135332 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baycare Home Care Inc | Largo, FL | Home health agency |
| Brandon Regional Hospital | Brandon, FL | Hospital |
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sunstate Physicians Llc | 3577813617 | 15 |
| Allied Im Llc | 6406074947 | 12 |
News Archive
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Rachel Shelton, ScD, MPH, Columbia Mailman School of Public Health assistant professor of Sociomedical Sciences, and Lisa Rosen-Metsch, PhD, dean of Columbia University's School of General Studies, received a planning grant award to focus on piloting Opioid Education and Naloxone Training on College Campuses.
A campaign to scale up the fight against HIV/AIDS through youth leadership, called "Wake up Pune," has planned several activities in the Indian city of Pune between Sept. 7 and Dec. 1, the Times of India reports.
Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.
MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.
› Verified 8 days ago
| Entity Name | Allied Im Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295140325 PECOS PAC ID: 6406074947 Enrollment ID: O20140826000925 |
News Archive
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Rachel Shelton, ScD, MPH, Columbia Mailman School of Public Health assistant professor of Sociomedical Sciences, and Lisa Rosen-Metsch, PhD, dean of Columbia University's School of General Studies, received a planning grant award to focus on piloting Opioid Education and Naloxone Training on College Campuses.
A campaign to scale up the fight against HIV/AIDS through youth leadership, called "Wake up Pune," has planned several activities in the Indian city of Pune between Sept. 7 and Dec. 1, the Times of India reports.
Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.
MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.
› Verified 8 days ago
| Entity Name | Sunstate Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750872545 PECOS PAC ID: 3577813617 Enrollment ID: O20180911001343 |
News Archive
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Rachel Shelton, ScD, MPH, Columbia Mailman School of Public Health assistant professor of Sociomedical Sciences, and Lisa Rosen-Metsch, PhD, dean of Columbia University's School of General Studies, received a planning grant award to focus on piloting Opioid Education and Naloxone Training on College Campuses.
A campaign to scale up the fight against HIV/AIDS through youth leadership, called "Wake up Pune," has planned several activities in the Indian city of Pune between Sept. 7 and Dec. 1, the Times of India reports.
Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.
MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.
› Verified 8 days ago
| Entity Name | Hospital Medicine Services Of Fl, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710684857 PECOS PAC ID: 9234596743 Enrollment ID: O20230526001457 |
News Archive
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Rachel Shelton, ScD, MPH, Columbia Mailman School of Public Health assistant professor of Sociomedical Sciences, and Lisa Rosen-Metsch, PhD, dean of Columbia University's School of General Studies, received a planning grant award to focus on piloting Opioid Education and Naloxone Training on College Campuses.
A campaign to scale up the fight against HIV/AIDS through youth leadership, called "Wake up Pune," has planned several activities in the Indian city of Pune between Sept. 7 and Dec. 1, the Times of India reports.
Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.
MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Syed Mustafa Zaidi, Po Box 320848, Tampa, FL 33679-2848 Ph: (407) 788-1906 | Syed Mustafa Zaidi, 119 Oakfield Dr, Brandon, FL 33511-5779 Ph: (407) 788-1906 |
News Archive
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Rachel Shelton, ScD, MPH, Columbia Mailman School of Public Health assistant professor of Sociomedical Sciences, and Lisa Rosen-Metsch, PhD, dean of Columbia University's School of General Studies, received a planning grant award to focus on piloting Opioid Education and Naloxone Training on College Campuses.
A campaign to scale up the fight against HIV/AIDS through youth leadership, called "Wake up Pune," has planned several activities in the Indian city of Pune between Sept. 7 and Dec. 1, the Times of India reports.
Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.
MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.
› Verified 8 days ago
Dr. Joanna G Ramirez, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 Morrison Rd, Ste 110, Brandon, FL 33511 Phone: 813-844-4300 Fax: 813-844-1909 | |
Harshinder Singh, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1159 Nikki View Dr, Brandon, FL 33511 Phone: 813-996-7272 Fax: 813-634-4306 | |
Jonathan P Axel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 631 W Lumsden Rd, Brandon, FL 33511 Phone: 813-413-9119 Fax: 813-413-9122 | |
Dr. Monther Hafez Al-halawani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 Corner Dr, Brandon, FL 33511 Phone: 813-643-4722 Fax: 813-651-3280 | |
Dr. Elizabeth J Carpenter, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 Noland Dr, Brandon, FL 33511 Phone: 813-333-1601 | |
Michael L Davis, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1218 Millennium Pkwy, Brandon, FL 33511 Phone: 813-684-5255 Fax: 813-654-7457 |